Table of Contents

1. Executive Summary

2. United States Diabetes Population (2011 – 2022): An Analysis
2.1 Overall Diabetes Population
2.1.1 Type 1 Diabetes
2.1.2 Type 2 Diabetes
2.1.3 Newly Diagnosed Type 1 Diabetes

3. United States Insulin Pump Market Analysis (2011–  2022)
3.1 Insulin Pump Users
3.1.1 Type 1 Diabetes Insulin Pump Users
3.1.2 Type 2 Diabetes Insulin Pump Users
3.2 Insulin Pump Market

4. Key Drivers and Inhibitors of the United States Insulin Pump Market
4.1 Market Drivers
4.2 Inhibitors

5. United States Insulin Pump Preferred Brand – By Product
5.1 Pediatric
5.2 Adult

6. United States Insulin Pump Market: Reimbursement & Regulation System
6.1 Reimbursement System
6.2 Regulation System

7. United States Insulin Pump Market – Major Deal Types
7.1 Insulin Pump Market – Collaboration Deals
7.2 Insulin Pump Market – Licensing Agreement
7.3 Insulin Pump Market – Exclusive Agreement
7.4 Insulin Pump Market – Partnerships Deals

8. Insulin Pump Market Clinical Trail Insight by Phase, Company & Country
8.1 Year 2016
8.2 Year 2015
8.3 Year 2014
8.4 Year 2013
8.5 Year 2012

9. Key Companies Analysis
9.1 Medtronic
9.1.1 Business Overview
9.1.2 Insulin Pump – Product Details
9.1.3 Medtronic – United States Diabetes Sales Analysis & Forecast (2013 – 2022)
9.1.4 Insulin Pump – Latest Development & Trends
9.2 Tandem Diabetes Care
9.2.1 Business Overview
9.2.2 Insulin Pump – Product Details
9.2.3 Tandem Diabetes Care – Insulin Pump Sales Analysis & Forecast (2013 – 2022)
9.2.4 Insulin Pump – Latest Development & Trends
9.3 Insulet Corporation
9.3.1 Business Overview
9.3.2 Insulin Pump – Product Details
9.3.3 Insulet Corporation – Insulin Pump Sales Analysis & Forecast (2011 – 2022)
9.3.4 Insulin Pump – Latest Development & Trends
9.4 Animas Corporation (Johnson & Johnson)
9.4.1 Business Overview
9.4.2 Insulin Pump – Product Details
9.4.3 Johnson & Johnson – United States Diabetes Sales Analysis & Forecast (2013 – 2022)
9.4.4 Insulin Pump – Latest Development & Trends
9.5 Roche
9.5.1 Business Overview
9.5.2 Insulin Pump – Product Details
9.5.3 Roche – North America Diabetes Sales Analysis & Forecast (2011 – 2022)
9.5.4 Insulin Pump – Latest Development & Trends

List of Tables

Table 7–1: Collaboration Deals in Insulin Pump Market, 2009 – 2016
Table 7–2: Licensing Agreement in Insulin Pump Market, 2009 – 2016
Table 7–3: Exclusive Agreement in Insulin Pump Market, 2011 – 2016
Table 7–4: Partnerships Deals in Insulin Pump Market, 2010 – 2016

List of Figures

Figure 2–1: United States – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 2–2: United States – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 2–3: United States – Type 1 Diabetes Population (Thousand), 2011 – 2016
Figure 2–4: United States – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure 2–5: United States – Type 2 Diabetes Population (Thousand), 2011 – 2016
Figure 2–6: United States – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure 2–7: United States – Newly Diagnosed Type 1 Diabetes Population (Number), 2011 – 2016
Figure 2–8: United States – Forecast for Newly Diagnosed Type 1 Diabetes Population (Number), 2017 – 2022

Figure 3–1: United States – Insulin Pump Users (Number), 2011 – 2016
Figure 3–2: United States – Forecast for Insulin Pump Users (Number), 2017 – 2022
Figure 3–3: United States – Type 1 Diabetes Insulin Pump Users (Number), 2011 – 2016
Figure 3–4: United States – Forecast for Type 1 Diabetes Insulin Pump Users (Number), 2017 – 2022
Figure 3–5: United States – Type 2 Diabetes Insulin Pump Users (Number), 2011 – 2016
Figure 3–6: United States – Forecast for Type 2 Diabetes Insulin Pump Users (Number), 2017 – 2022
Figure 3–7: United States – Insulin Pump Market (Million US$), 2011 – 2016
Figure 3–8: United States – Forecast for Insulin Pump Market (Million US$), 2017 – 2022

Figure 9–1: Medtronic – United States Diabetes Sales Analysis (Million US$),2013 – 2016
Figure 9–2: Medtronic – Forecast for United States Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 9–3: Tandem Diabetes Care – Insulin Pump Sales Analysis (Million US$),2013 – 2016
Figure 9–4: Tandem Diabetes Care – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
Figure 9–5: Insulet Corporation – Insulin Pump Sales Analysis (Million US$),2011 – 2016
Figure 9–6: Insulet Corporation – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
Figure 9–7: Johnson & Johnson – United States Diabetes Sales Analysis (Million US$),2013 – 2016
Figure 9–8: Johnson & Johnson – United States Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 9–9: Roche – North America Diabetes Sales Analysis (Million US$),2011 – 2016
Figure 9–10: Roche – Forecast for North America Diabetes Sales Analysis (Million US$),2017 – 2022